Descripción de negocio
BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech’s investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science.
Consejo de gestión & Consejo de supervisión
| CEO |
| Dr. Daniel Koller |
| Consejo de gestión |
| Dr. Thomas von Planta, Laura Hamill, Dr. Pearl Huang, Prof. Dr. Mads Krogsgaard Thomsen, Camilla Soenderby |
| Consejo de supervisión |
| Dr. Clive Meanwell |
Datos de la empresa
| Nombre: |
BB Biotech AG |
| Dirección: |
Schwertstraße 6,CH-8200 Schaffhausen/Schweiz |
| Teléfono: |
+41-52-624-0845 |
| Fax: |
- |
| E-mail: |
info@bbbiotech.com
|
| Internet: |
www.bbbiotech.com |
| Industria: |
Financial |
| Sector: |
Specialty Finance |
| Subsector: |
Diversified Financial |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
97.00% |
| Fecha de OPI: |
10/12/1997 |
Relación con inversores
| Nombre: |
Dr. Silvia Siegfried-Schanz |
| IR teléfono: |
+41-44-267-7266 |
| IR-fax: |
- |
| IR e-mail: |
ssc@bellevue.ch
|
